BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 20188661)

  • 21. When epigenetics kills: MLL fusion proteins in leukemia.
    Slany RK
    Hematol Oncol; 2005 Mar; 23(1):1-9. PubMed ID: 16118769
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MLL: a histone methyltransferase disrupted in leukemia.
    Hess JL
    Trends Mol Med; 2004 Oct; 10(10):500-7. PubMed ID: 15464450
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The mixed lineage leukemia (MLL) fusion-associated gene AF4 promotes CD133 transcription.
    Mak AB; Nixon AM; Moffat J
    Cancer Res; 2012 Apr; 72(8):1929-34. PubMed ID: 22337994
    [TBL] [Abstract][Full Text] [Related]  

  • 24. hDOT1L links histone methylation to leukemogenesis.
    Okada Y; Feng Q; Lin Y; Jiang Q; Li Y; Coffield VM; Su L; Xu G; Zhang Y
    Cell; 2005 Apr; 121(2):167-78. PubMed ID: 15851025
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of MLL-fusion/MYC⊣miR-26⊣TET1 signaling circuit in MLL-rearranged leukemia.
    Huang H; Jiang X; Wang J; Li Y; Song CX; Chen P; Li S; Gurbuxani S; Arnovitz S; Wang Y; Weng H; Neilly MB; He C; Li Z; Chen J
    Cancer Lett; 2016 Mar; 372(2):157-65. PubMed ID: 26791235
    [TBL] [Abstract][Full Text] [Related]  

  • 26. t(10;11)-acute leukemias with MLL-AF10 and MLL-ABI1 chimeric transcripts: specific expression patterns of ABI1 gene in leukemia and solid tumor cell lines.
    Shibuya N; Taki T; Mugishima H; Chin M; Tsuchida M; Sako M; Kawa K; Ishii E; Miura I; Yanagisawa M; Hayashi Y
    Genes Chromosomes Cancer; 2001 Sep; 32(1):1-10. PubMed ID: 11477655
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The leukemogenic AF4-MLL fusion protein causes P-TEFb kinase activation and altered epigenetic signatures.
    Benedikt A; Baltruschat S; Scholz B; Bursen A; Arrey TN; Meyer B; Varagnolo L; Müller AM; Karas M; Dingermann T; Marschalek R
    Leukemia; 2011 Jan; 25(1):135-44. PubMed ID: 21030982
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MLL-ENL-mediated leukemia initiation at the interface of lymphoid commitment.
    Ugale A; Säwén P; Dudenhöffer-Pfeifer M; Wahlestedt M; Norddahl GL; Bryder D
    Oncogene; 2017 Jun; 36(22):3207-3212. PubMed ID: 28068328
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The elongation factor ELL (eleven-nineteen lysine-rich leukemia) is a selective coregulator for steroid receptor functions.
    Pascual-Le Tallec L; Simone F; Viengchareun S; Meduri G; Thirman MJ; Lombès M
    Mol Endocrinol; 2005 May; 19(5):1158-69. PubMed ID: 15650021
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A distinct set of long non-coding RNAs in childhood MLL-rearranged acute lymphoblastic leukemia: biology and epigenetic target.
    Fang K; Han BW; Chen ZH; Lin KY; Zeng CW; Li XJ; Li JH; Luo XQ; Chen YQ
    Hum Mol Genet; 2014 Jun; 23(12):3278-88. PubMed ID: 24488769
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impairing MLL-fusion gene-mediated transformation by dissecting critical interactions with the lens epithelium-derived growth factor (LEDGF/p75).
    Méreau H; De Rijck J; Cermáková K; Kutz A; Juge S; Demeulemeester J; Gijsbers R; Christ F; Debyser Z; Schwaller J
    Leukemia; 2013 Jun; 27(6):1245-53. PubMed ID: 23318960
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A MENage à Trois in leukemia.
    Roudaia L; Speck NA
    Cancer Cell; 2008 Jul; 14(1):3-5. PubMed ID: 18598937
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular mechanisms of MLL-associated leukemia.
    Yokoyama A
    Int J Hematol; 2015 Apr; 101(4):352-61. PubMed ID: 25773519
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel sub-cellular localizations and intra-molecular interactions may define new functions of Mixed Lineage Leukemia protein.
    Karole AM; Chodisetty S; Ali A; Kumari N; Tyagi S
    Cell Cycle; 2018; 17(24):2684-2696. PubMed ID: 30489191
    [TBL] [Abstract][Full Text] [Related]  

  • 35. AF4 uses the SL1 components of RNAP1 machinery to initiate MLL fusion- and AEP-dependent transcription.
    Okuda H; Kanai A; Ito S; Matsui H; Yokoyama A
    Nat Commun; 2015 Nov; 6():8869. PubMed ID: 26593443
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The menin tumor suppressor protein is an essential oncogenic cofactor for MLL-associated leukemogenesis.
    Yokoyama A; Somervaille TC; Smith KS; Rozenblatt-Rosen O; Meyerson M; Cleary ML
    Cell; 2005 Oct; 123(2):207-18. PubMed ID: 16239140
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Leukemogenic MLL fusion proteins bind across a broad region of the Hox a9 locus, promoting transcription and multiple histone modifications.
    Milne TA; Martin ME; Brock HW; Slany RK; Hess JL
    Cancer Res; 2005 Dec; 65(24):11367-74. PubMed ID: 16357144
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estradiol induces gene proximity and MLL-MLLT3 fusion in an activation-induced cytidine deaminase-mediated pathway.
    Wright RL; Slemmons KK; Vaughan AT
    Leuk Lymphoma; 2015 May; 56(5):1460-5. PubMed ID: 25130479
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epigenetic roles of MLL oncoproteins are dependent on NF-κB.
    Kuo HP; Wang Z; Lee DF; Iwasaki M; Duque-Afonso J; Wong SH; Lin CH; Figueroa ME; Su J; Lemischka IR; Cleary ML
    Cancer Cell; 2013 Oct; 24(4):423-37. PubMed ID: 24054986
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical outcome and monitoring of minimal residual disease in patients with acute lymphoblastic leukemia expressing the MLL/ENL fusion gene.
    Elia L; Grammatico S; Paoloni F; Vignetti M; Rago A; Cenfra N; Mecarocci S; Mancini M; Luciani M; Di Raimondo F; Cazzaniga G; Matarazzo M; Moleti ML; Santoro L; Gaidano G; Foà R; Mandelli F; Cimino G
    Am J Hematol; 2011 Dec; 86(12):993-7. PubMed ID: 21953510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.